Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells-Reference-Cited by-同舟云学术

Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells

Published:2016-07-07 Issue:7 Volume:11 Page:e0158290
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Abe Mariko,Pelus Louis M.,Singh Pratibha,Hirade Tomohiro,Onishi Chie,Purevsuren Jamiyan,Taketani Takeshi,Yamaguchi Seiji,Fukuda Seiji

Funder

Japan Society for the Promotion of Science

National Heart, Lung, and Blood Institute

Japan Leukemia Research Fund

Research Support Funds from the Mochida Memorial Foundation for Medical and Pharmaceutical Research

Sankyo Biomedical Research Foundation and the Mitsubishi Pharma Research Foundation

AstraZeneca Research Grant

Naito Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. WAF1, a potential mediator of p53 tumor suppression;W el-Deiry;Cell,1993

2. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases;J Wade Harper;Cell,1993

3. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor;MA Rego;Oncogene,2012

4. The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO;LF Peterson;Blood,2007

5. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier;MA Santos;Nature,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

2. Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia;iScience;2023-06

3. The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD+ cells via RUNX1;Leukemia Research;2023-01

4. Single-cell characterisation of the hematopoietic bone marrow interactome in health and disease;2022-05-13

5. Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3;Archives of Toxicology;2021-10-19